Qube Research & Technologies (QRT)’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BIB Stock Details BIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.08K	Sell	50 -3	-6%	-$249	﹤0.01%	3402
2025 Q4	$4.23K	Hold	53	–	–	﹤0.01%	3538
2025 Q3	$3.16K	Hold	53	–	–	﹤0.01%	3448
2025 Q2	$2.43K	Hold	53	–	–	﹤0.01%	3457
2025 Q1	$2.55K	Hold	53	–	–	﹤0.01%	3391
2024 Q4	$2.69K	Hold	53	–	–	﹤0.01%	3358
2024 Q3	$3.38K	Hold	53	–	–	﹤0.01%	3139
2024 Q2	$3.14K	Sell	53 -414	-89%	-$22.9K	﹤0.01%	3122
2024 Q1	$26.9K	Hold	467	–	–	﹤0.01%	3632
2023 Q4	$26.6K	Sell	467 -26	-5%	-$1.22K	﹤0.01%	3437
2023 Q3	$23.6K	Sell	493 -1,179	-71%	-$60.6K	﹤0.01%	3102
2023 Q2	$76.3K	Buy	1,672 +1,621	+3,178%	+$89.3K	﹤0.01%	2002
2023 Q1	$2.76K	Sell	51 -27	-35%	-$1.52K	﹤0.01%	2438
2022 Q4	$4.5K	Sell	78 -305	-80%	-$17.2K	﹤0.01%	2337
2022 Q3	$18K	Buy	383 +129	+51%	+$6.88K	﹤0.01%	2309
2022 Q2	$12K	Buy	+254	New	+$12.9K	﹤0.01%	2309
2022 Q1	–	Sell	-1,368	Closed	-$111K	–	2456
2021 Q4	$111K	Buy	+1,368	New	+$117K	﹤0.01%	2121

Other funds holding BIB

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return

KFS

Kaizen Financial Strategies Campbell, California $308M AUM 41.73% 1-Year Est. Return

PWM

Palumbo Wealth Management Great Neck, New York $410M AUM 32.56% 1-Year Est. Return

CAG

Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BIB Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its ProShares Ultra NASDAQ Biotechnology (BIB) stake by 5.7% in Q1 2026, selling an estimated $249 and leaving 50 shares worth $4.08K. The position accounts for ﹤0.01% of the portfolio, ranked #3402.

Qube Research & Technologies (QRT) first reported a position in BIB in Q4 2021 and has held it in 17 quarters since. The position peaked at $111K in Q4 2021. 23 funds tracked by Wall St. Rank hold BIB as of Q1 2026.

Qube Research & Technologies (QRT) held 50 shares of ProShares Ultra NASDAQ Biotechnology worth $4.08K as of Q1 2026.
Qube Research & Technologies (QRT) sold 3 ProShares Ultra NASDAQ Biotechnology shares in Q1 2026, an estimated $249.
ProShares Ultra NASDAQ Biotechnology made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #3402 holding.
Qube Research & Technologies (QRT) first reported a position in ProShares Ultra NASDAQ Biotechnology in Q4 2021 and has held it in 17 quarters since.
Qube Research & Technologies (QRT)'s ProShares Ultra NASDAQ Biotechnology position peaked at $111K in Q4 2021.
23 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.